AAAAAA

   
Results: 1-6 |
Results: 6
SPECIES-DIFFERENCES IN THE METABOLISM OF A POTENT HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR L-738,372 - IN-VIVO AND IN-VITRO STUDIES IN RATS, DOGS, MONKEYS, AND HUMANS
Authors: PRUEKSARITANONT T BALANI SK DWYER LM ELLIS JD KAUFFMAN LR VARGA SL PITZENBERGER SM THEOHARIDES AD
Citation: T. Prueksaritanont et al., SPECIES-DIFFERENCES IN THE METABOLISM OF A POTENT HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR L-738,372 - IN-VIVO AND IN-VITRO STUDIES IN RATS, DOGS, MONKEYS, AND HUMANS, Drug metabolism and disposition, 23(7), 1995, pp. 688-695
PHARMACOKINETICS AND PHARMACODYNAMICS OF L-703,014, A POTENT FIBRINOGEN RECEPTOR ANTAGONIST, AFTER INTRAVENOUS AND ORAL-ADMINISTRATION IN THE DOG
Authors: BARRETT JS GOULD RJ ELLIS JD HOLAHAN MM STRANIERI MT LYNCH JJ HARTMAN GD IHLE N DUGGAN M MORENO OA THEOHARIDES AD
Citation: Js. Barrett et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF L-703,014, A POTENT FIBRINOGEN RECEPTOR ANTAGONIST, AFTER INTRAVENOUS AND ORAL-ADMINISTRATION IN THE DOG, Pharmaceutical research, 11(3), 1994, pp. 426-431
IN-VITRO METABOLISM OF L-696,229, AN HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR IN RATS AND HUMANS - HEPATIC AND EXTRAHEPATIC METABOLISM AND IDENTIFICATION OF ENZYMES INVOLVED IN THE HEPATIC-METABOLISM
Authors: PRUEKSARITANONT T DWYER LM BALANI SK THEOHARIDES AD
Citation: T. Prueksaritanont et al., IN-VITRO METABOLISM OF L-696,229, AN HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR IN RATS AND HUMANS - HEPATIC AND EXTRAHEPATIC METABOLISM AND IDENTIFICATION OF ENZYMES INVOLVED IN THE HEPATIC-METABOLISM, Drug metabolism and disposition, 22(2), 1994, pp. 281-288
CHARACTERIZATION OF L-703,014, A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST, FOLLOWING ORAL-ADMINISTRATION TO DOGS
Authors: GOULD RJ BARRETT JS ELLIS JD HOLAHAN MA STRANIERI MT THEOHARIDES AD LYNCH JJ FRIEDMAN PA DUGGAN ME IHLE NC ANDERSON PS HARTMAN GD
Citation: Rj. Gould et al., CHARACTERIZATION OF L-703,014, A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST, FOLLOWING ORAL-ADMINISTRATION TO DOGS, Thrombosis and haemostasis, 69(6), 1993, pp. 539-539
BIOTRANSFORMATION OF 5-CHLORO-3-PHENYLTHIOINDOLE-2-CARBOXAMIDE (L-734,005) IN RHESUS-MONKEYS AND RAT-LIVER MICROSOMES TO A POTENT HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR
Authors: BALANI SK GOLDMAN ME KAUFFMAN LR VARGA SL OBRIEN JA SMITH SJ OLAH TV RAMJIT HG SCHORN TW PITZENBERGER SM WILLIAMS TM ROONEY CS THEOHARIDES AD
Citation: Sk. Balani et al., BIOTRANSFORMATION OF 5-CHLORO-3-PHENYLTHIOINDOLE-2-CARBOXAMIDE (L-734,005) IN RHESUS-MONKEYS AND RAT-LIVER MICROSOMES TO A POTENT HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR, Drug metabolism and disposition, 21(4), 1993, pp. 598-604
5-CHLORO-3-(PHENYLSULFONYL)INDOLE-2-CARBOXAMIDE - A NOVEL, NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE
Authors: WILLIAMS TM CICCARONE TM MACTOUGH SC ROONEY CS BALANI SK CONDRA JH EMINI EA GOLDMAN ME GREENLEE WJ KAUFFMAN LR OBRIEN JA SARDANA VV SCHLEIF WA THEOHARIDES AD ANDERSON PS
Citation: Tm. Williams et al., 5-CHLORO-3-(PHENYLSULFONYL)INDOLE-2-CARBOXAMIDE - A NOVEL, NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE, Journal of medicinal chemistry, 36(9), 1993, pp. 1291-1294
Risultati: 1-6 |